F. Rosenkaimer

发表

Oral treatment of visceral leishmaniasis with miltefosine.

S. Sundar, J. Engel, H. Murray, 1999, Annals of tropical medicine and parasitology.

A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-γ in the local treatment of cutaneous leishmaniasis

U. Bienzle, M. Roepke, G. Harms, 1991 .

Rationale for using TNFα and chemotherapy in regional therapy of melanoma

A. Eggermont, A. Eggermont, P. Schmitz, 1994 .

Clinical Experiences with lnterferon-α and Interferon-γ

G. Leitz, G. Steinmann, F. Rosenkaimer, 1993 .

Administration of high-dose tumor necrosis factor alpha by isolation perfusion of the limbs. Rationale and results.

A. Eggermont, P. Schmitz, J. Gérain, 1995, The Journal of infusional chemotherapy.

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

A. Eggermont, P. Schmitz, B. Kroon, 1999, Melanoma research.

Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study.

A. Eggermont, P. Autier, B. Kroon, 1994, Melanoma research.

Recombinant tumor necrosis factor for superficial bladder tumors.

C. Sternberg, I. D'Agnano, G. Zupi, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Inefficacy of topical alpha interferon in the treatment of oral ulcers of Behçet's syndrome: a randomized, double blind trial.

H. Yazıcı, S. Yurdakul, V. Hamuryudan, 1991, British journal of rheumatology.

Topical alpha interferon in the treatment of oral ulcers in Behçet's syndrome: a preliminary report.

H. Yazıcı, Y. Tüzün, S. Serdaroğlu, 1990, Clinical and experimental rheumatology.

Oral treatment of visceral leishmaniasis with miltefosine.

S. Sundar, J. Engel, H. Murray, 1999, Annals of tropical medicine and parasitology.

Successful Treatment Of Refractory Visceral Leishmaniasis In India Using Antimony Plus Interferon-ã

S. Sundar, H. Murray, F. Rosenkaimer, 1994 .

Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma.

S. Sundar, H. Murray, F. Rosenkaimer, 1994, The Journal of infectious diseases.

Low incidence of antibody formation due to long-term interferon-α2c treatment of cancer patients

E. Patzelt, G. Steinmann, H. Lamche, 1992, The clinical investigator.

Clinical experiences with interferon-alpha and interferon-gamma.

G. Leitz, G. Steinmann, F. Rosenkaimer, 1993, International review of experimental pathology.

Efficacy of a short course (10 days) of high-dose meglumine antimonate with or without interferon-gamma in treating cutaneous leishmaniasis in Guatemala.

B. Arana, J. Berman, T. Navin, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.

U. Bienzle, M. Roepke, G. Harms, 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Comparison of different methods for the detection of intestinal protozoa and helminths in stool.

M. Dietrich, U. Bienzle, F. Rosenkaimer, 1978, Tropenmedizin und Parasitologie.

Genetic studies in Cameroon: red cell enzyme and serum protein polymorphisms.

D. Agarwal, B. Brinkmann, U. Bienzle, 1979, Zeitschrift fur Morphologie und Anthropologie.

High dose tumor necrosis factor alpha in isolation perfusion of the limb : highly effective treatment for melanoma in transit metastases or unresectable sarcomas

A. Eggermont, P. Schmitz, B. Kroon, 1995 .

Treatment of Irresectable Soft Tissue Sarcomas of the Limbs by Isolation Perfusion with High Dose TNFα in Combination with Interferon-γ and Melphalan

A. Eggermont, F. Lejeune, H. Koops, 1993 .

Clinical experience with high-dose tumor necrosis factor alpha in regional therapy of advanced melanoma.

A. Eggermont, P. Schmitz, J. Gérain, 1994, Circulatory shock.

High-Dose Tumor Necrosis Factor-α in Combination with Interferon-γ and Melphalan in Isolated Perfusion of the Limb for Irresectable Soft Tissue Sarcomas: A Highly Effective Approach to Achieve Limb Salvage

A. Eggermont, F. Lejeune, H. Koops, 1994 .

[Efficacy of the tumor necrosis factor-alpha (rTNF-alpha) associated with interferon-gamma and chemotherapy in extracorporeal circulation in the limb in inoperable malignant melanoma, soft tissue sarcoma and epidermoid carcinoma. A 4-year experience].

A. Eggermont, P. Schmitz, J. Gérain, 1995, Bulletin du Cancer.

Trial of oral miltefosine for visceral leishmaniasis

S. Sundar, H. Murray, M. Makharia, 1998, The Lancet.

Immunochemotherapy for a systemic intracellular infection: accelerated response using interferon-gamma in visceral leishmaniasis.

S. Sundar, H. Murray, M. Lesser, 1995, The Journal of infectious diseases.

Immunochemotherapy of visceral leishmaniasis: a pilot trial of sequential treatment with recombinant interferon-gamma and pentavalent antimony.

J. Richter, U. Bienzle, G. Harms, 1993, Journal of interferon research.

Immunochemotherapy for visceral leishmaniasis: a controlled pilot trial of antimony versus antimony plus interferon-gamma.

K. Squires, H. Murray, J. Sherwood, 1993, The American journal of tropical medicine and hygiene.

Inhibition of Plasmodium vinckei-malaria in mice by recombinant murine interferon-gamma.

P. Kremsner, U. Bienzle, H. Feldmeier, 1988, Acta tropica.